{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:37:16Z","timestamp":1773938236659,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,17]]},"DOI":"10.7759\/cureus.43671","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T03:51:02Z","timestamp":1692330662000},"source":"Crossref","is-referenced-by-count":1,"title":["Compassionate Use of Remdesivir in Pregnancy: A Case Series From a COVID-19 Dedicated Center and Review of Literature"],"prefix":"10.7759","author":[{"given":"Priyanka","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi","family":"Virmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagadish C","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avir","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.02.011","article-title":"Higher severe acute respiratory syndrome coronavirus 2 infection rate in pregnant patients","volume":"225","author":"Lokken EM","year":"2021","unstructured":"Lokken EM, Taylor GG, Huebner EM, et al.. Higher severe acute respiratory syndrome coronavirus 2 infection rate in pregnant patients. Am J Obstet Gynecol. 2021, 225:75.e1-75.e16. 10.1016\/j.ajog.2021.02.011","journal-title":"Am J Obstet Gynecol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2107","article-title":"Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study","volume":"369","author":"Knight M","year":"2020","unstructured":"Knight M, Bunch K, Vousden N, et al.. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ. 2020, 369:m2107. 10.1136\/bmj.m2107","journal-title":"BMJ"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/20587384211048026","article-title":"A scoping review of the pathophysiology of COVID-19","volume":"35","author":"Marik PE","year":"2021","unstructured":"Marik PE, Iglesias J, Varon J, Kory P. A scoping review of the pathophysiology of COVID-19. Int J Immunopathol Pharmacol. 2021, 35:20587384211048026. 10.1177\/20587384211048026","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref4","unstructured":"World Health Organization. WHO Coronavirus (COVID 19) Dashboard. (2020). Accessed. February 19, 2022: https:\/\/coronavirus\/vaccine\/summary-of-yellow-card-reporting\/files\/COVID-19-VaccineOG111."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-08-102723-3.00187-6","article-title":"Management of coronavirus disease 2019 (COVID-19) pneumonia","author":"Thirkell P","year":"2021","unstructured":"Thirkell P, Griffiths M, Waller MD. Management of coronavirus disease 2019 (COVID-19) pneumonia. Encyclopedia of Respiratory Medicine. 2021, 342-9. 10.1016\/B978-0-08-102723-3.00187-6","journal-title":"Encyclopedia of Respiratory Medicine"},{"key":"ref6","unstructured":"COVID-19 treatment guidelines panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. (2022). Accessed. February 2, 2022: https:\/\/www.covid19treatmentguidelines.nih.gov\/."},{"key":"ref7","unstructured":"AIIMS\/ ICMR-COVID-19 National Task Force\/Joint Monitoring Group (Dte.GHS). MOHFW. (2022). Accessed. February 1, 2022: https:\/\/www.icmr.gov.in\/pdf\/covid\/techdoc\/COVID_Clinical_Management_19032023.pdf."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00221-18","article-title":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease","volume":"9","author":"Agostini ML","year":"2018","unstructured":"Agostini ML, Andres EL, Sims AC, et al.. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio. 2018, 9:10.1128\/mBio.00221-18","journal-title":"mBio"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan TP","year":"2020","unstructured":"Sheahan TP, Sims AC, Leist SR, et al.. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun. 2020, 11:222. 10.1038\/s41467-019-13940-6","journal-title":"Nat Commun"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19487","article-title":"Evaluating the clinical outcomes of remdesivir among patients admitted with COVID-19 in a tertiary care hospital","volume":"13","author":"Butt AG","year":"2021","unstructured":"Butt AG, Ahmed J, Shah SM, et al.. Evaluating the clinical outcomes of remdesivir among patients admitted with COVID-19 in a tertiary care hospital. Cureus. 2021, 13:e19487. 10.7759\/cureus.19487","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104786","article-title":"Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro","volume":"178","author":"Choy KT","year":"2020","unstructured":"Choy KT, Wong AY, Kaewpreedee P, et al.. Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antiviral Res. 2020, 178:104786. 10.1016\/j.antiviral.2020.104786","journal-title":"Antiviral Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2423-5","article-title":"Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2","volume":"585","author":"Williamson BN","year":"2020","unstructured":"Williamson BN, Feldmann F, Schwarz B, et al.. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. Nature. 2020, 585:273-6. 10.1038\/s41586-020-2423-5","journal-title":"Nature"},{"key":"ref13","unstructured":"European Medicines Agency. Human Medicines Division. Summary on compassionate use. Remdesivir Gilead. (2022). Accessed. Januar 20, 2022: https:\/\/www.ema.europa.eu\/en\/documents\/other\/summary-compassionate-use-remdesivir-gilead_en.pdf."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 - final report","volume":"383","author":"Beigel JH","year":"2020","unstructured":"Beigel JH, Tomashek KM, Dodd LE, et al.. Remdesivir for the treatment of Covid-19 - final report. N Engl J Med. 2020, 383:1813-26. 10.1056\/NEJMoa2007764","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed antiviral drugs for Covid-19 - interim WHO Solidarity trial results","volume":"384","author":"Pan H","year":"2021","unstructured":"Pan H, Peto R, Henao-Restrepo AM, et al.. Repurposed antiviral drugs for Covid-19 - interim WHO Solidarity trial results. N Engl J Med. 2021, 384:497-511. 10.1056\/NEJMoa2023184","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1466","article-title":"Compassionate use of remdesivir in pregnant women with severe coronavirus disease 2019","volume":"73","author":"Burwick RM","year":"2021","unstructured":"Burwick RM, Yawetz S, Stephenson KE, et al.. Compassionate use of remdesivir in pregnant women with severe coronavirus disease 2019. Clin Infect Dis. 2021, 73:e3996-4004. 10.1093\/cid\/ciaa1466","journal-title":"Clin Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2021.1903426","article-title":"Pharmacological treatment in pregnant women with moderate symptoms of coronavirus disease 2019 (COVID-19) pneumonia","volume":"35","author":"Nasrallah S","year":"2022","unstructured":"Nasrallah S, Nguyen AQ, Hitchings L, et al.. Pharmacological treatment in pregnant women with moderate symptoms of coronavirus disease 2019 (COVID-19) pneumonia. J Matern Fetal Neonatal Med. 2022, 35:5970-7. 10.1080\/14767058.2021.1903426","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5591041","article-title":"A clinical study on initial experience of COVID-19 ARDS in obstetric patients at a tertiary care centre in India","volume":"2021","author":"Marwah S","year":"2021","unstructured":"Marwah S, Kanwar R, Naghma S, Dabral A, Gupta N. A clinical study on initial experience of COVID-19 ARDS in obstetric patients at a tertiary care centre in India. Case Rep Obstet Gynecol. 2021, 2021:5591041. 10.1155\/2021\/5591041","journal-title":"Case Rep Obstet Gynecol"},{"key":"ref19","unstructured":"Prescribing information. (2022). Accessed. 20\/01\/2022: https:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?setid=c0978fa8-53ff-4ca2-82a7-7fd3e958ca#data."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910993","article-title":"A randomized, controlled trial of Ebola virus disease therapeutics","volume":"381","author":"Mulangu S","year":"2019","unstructured":"Mulangu S, Dodd LE, Davey RT Jr, et al.. A randomized, controlled trial of Ebola virus disease therapeutics. N Engl J Med. 2019, 381:2293-303. 10.1056\/NEJMoa1910993","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10480","article-title":"Therapeutic options for COVID-19: a review","volume":"12","author":"Pujari R","year":"2020","unstructured":"Pujari R, Thommana MV, Ruiz Mercedes B, Serwat A. Therapeutic options for COVID-19: a review. Cureus. 2020, 12:e10480. 10.7759\/cureus.10480","journal-title":"Cureus"},{"key":"ref22","unstructured":"US FDA. Emergency use authorization for Veklury. Factsheet for health care workers . (2022). Accessed. February 20, 2022: https:\/\/www.fda.gov\/media\/137566\/download."},{"key":"ref23","unstructured":"US FDA news release. FDA approves first treatment for COVID 19. (2022). Accessed: February 10, 2022: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda approves-first-treatment-covid."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30484-8","article-title":"Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action","volume":"9","author":"Taylor MM","year":"2021","unstructured":"Taylor MM, Kobeissi L, Kim C, et al.. Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action. Lancet Glob Health. 2021, 9:e366-71. 10.1016\/S2214-109X(20)30484-8","journal-title":"Lancet Glob Health"},{"key":"ref25","unstructured":"National Institute of Health news releases. NIH funds study to evaluate remdesivir for COVID-19 in pregnancy. (2021). Accessed: 28\/07\/2022: http:\/\/https: \/\/www.nih.gov\/news-events.\/news-releases\/nih-funds-study-evaluate-remdesivir-covid-19-pregnancy."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/156102-compassionate-use-of-remdesivir-in-pregnancy-a-case-series-from-a-covid-19-dedicated-center-and-review-of-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:02:52Z","timestamp":1707508972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/156102-compassionate-use-of-remdesivir-in-pregnancy-a-case-series-from-a-covid-19-dedicated-center-and-review-of-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,17]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.43671","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,17]]}}}